English
Język Polski
Adaptability of clinical pharmacist led interventions in the management of anemia of chronic renal disease: optimizing care
Girish B S
Srinivasan R
Joel M. Johns
C S Meghana
Abstract
Renal anemia is a common comorbidity in chronic kidney disease (CKD) patients, typically treated with erythropoiesis-stimulating agents (ESAs) like erythropoietin. However, both over- and under-treatment are prevalent. In 2008, the Pharmacy Council of India introduced the Pharm.D course to enhance pharmaceutical care in clinical settings. While extensive studies in other countries highlight the benefits of clinical pharmacists' interventions, Indian research on this topic is limited. This prospective randomized controlled trial included CKD patients not on dialysis, with serum creatinine levels of 2-6 mg/dL and hemoglobin (Hb) levels below 12 g/dL. Participants were divided into three subgroups based on baseline Hb levels: < 10 g/dL (Group I), 10-12 g/dL (Group II), and >12 g/dL (Group III). ESAs and iron supplements were adjusted to maintain Hb levels of 10-12 g/dL. Quality of life was assessed using the Short Form Health Survey-36 questionnaire. Out of 448 participants, those in the pharmacist intervention group showed a significant shift towards Group II by the trial's end, compared to the control group. The study demonstrated a significant improvement in quality of life and physical performance, particularly for those in Group II, indicating that maintaining Hb levels at 10-12 g/dL is optimal for Indian CKD patients. This trial exemplifies the profound impact clinical pharmacists can have on patient care, highlighting their crucial role in improving healthcare outcomes through active participation and targeted interventions in clinical settings.
Keywords:
Chronic Kidney Disease, Anemia Management, Clinical Pharmacists Intervention, Pharmaceutical CareSimilar Articles
- Zofia Suchocka, OBESITY - REASONS AND TREATMENT , Prospects in Pharmaceutical Sciences: Vol. 1 No. 1 (2003)
- Wojciech Wahl, Dorota Jędrzejczyk-Okońska, Adam Fronczak, TOBACCO SMOKING EPIDEMIOLOGY AND EFFECTIVE NICOTINE ADDICTION CESSATION METHODS , Prospects in Pharmaceutical Sciences: Vol. 17 No. 5 (2019)
- Agata Pisula, Agnieszka Sienicka, Agnieszka Dobrowolska-Redo, Joanna Kacperczyk-Bartnik, Ewa Romejko-Wolniewicz, PARP inhibitors in ovarian cancer therapy , Prospects in Pharmaceutical Sciences: Vol. 22 No. 2 (2024)
- Agnieszka Sokal, Edyta Pindelska, COCRYSTALS - A NEW DRUG FORM , Prospects in Pharmaceutical Sciences: Vol. 11 No. 5 (2013)
- Alicja Stępień, Paweł Stępień, Julia Kornatowska, Dexmedetomidine as an additive to local anesthesia in dentistry , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
- Dariusz Łaszczych, Aleksandra Czernicka, Kornelia Kędziora-Kornatowska, Interaction between warfarin and selected superfoods: a comprehensive review of potential mechanisms and their clinical significance , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
- Agnieszka Lis-Cieplak, ADAMANTANE DERIVATIVES - VARIETY OF BIOLOGICAL ACTIVITIES. A REVIEW OF MEDICATIONS APPROVED IN POLAND AND POTENTIAL DRUGS , Prospects in Pharmaceutical Sciences: Vol. 10 No. 3 (2012)
- Falah Saleh Mohammed, İmran Uysal, Mustafa Sevindik, A review on antiviral pants effective against different virus types , Prospects in Pharmaceutical Sciences: Vol. 21 No. 2 (2023)
- Natalia Melnyk, Aleksandra Nyczka, Jakub P. Piwowarski, Sebastian Granica, Traditional Use of Chamomile Flowers (Matricariae flos) in Inflammatory-Associated Skin Disorders , Prospects in Pharmaceutical Sciences: Vol. 22 No. 4 (2024)
- Tomasz Pieńko, CAPSAICIN – PROPERTIES, APPLICATIONS TODAY AND FUTURE PROSPECTS , Prospects in Pharmaceutical Sciences: Vol. 11 No. 2 (2013)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
You may also start an advanced similarity search for this article.
Details
References
Statistics
Authors
Citation rules
Cited by / Share
Licence
This work is licensed under a Creative Commons Attribution 4.0 International License.